RISE: A Remote Study of Insomnia Treatment in Crohn's Disease

This study is testing a remote (telehealth) insomnia treatment program called RISE for people with Crohn's disease who also struggle with sleep. Poor sleep is very common in Crohn's disease and can worsen symptoms — this trial tests whether treating insomnia improves overall wellbeing. **You may be eligible if...** - You have mild to moderate Crohn's disease - You have an Insomnia Severity Index score of 8 or higher and trouble falling or staying asleep (30+ minutes of sleep disruption) - Your sleep and Crohn's medications have been stable for at least 3 months - You have access to the internet or sufficient cell phone service for telehealth **You may NOT be eligible if...** - You have significant depression or anxiety (high scores on depression or anxiety screening scales) - You have unstable major psychiatric conditions, such as bipolar disorder or psychosis - You currently use opioids for pain, systemic steroids, or alcohol/drugs - You are pregnant or nursing - You have an ileostomy, colostomy, seizure disorder, sleep apnea, or restless leg syndrome - You work night or rotating shifts, or frequently travel across time zones Talk to your doctor to see if this trial is right for you.